|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|
| Assets | ||||
| Current assets: | ||||
| Cash | ||||
| Prepaid expenses | ||||
| Total current assets | ||||
| Deferred offering cost | ||||
| Cash and marketable securities held in Trust Account | ||||
| Total Assets | ||||
| Liabilities, Redeemable Common Stock and Stockholders' (Deficit) Equity | ||||
| Current liabilities: | ||||
| Accrued offering costs and expenses | ||||
| Accounts payable and accrued expenses | ||||
| Promissory note - Related party | ||||
| Working capital loan - Related party | ||||
| Due to related party | ||||
| Total current liabilities | ||||
| Common stock subject to redemption, 11,500,000 shares at redemption value of $10.15 per share | ||||
| Stockholders' (Deficit) Equity | ||||
| Common stock, $0.0001 par value; 500,000,000 shares authorized; 2,875,000 shares issued and outstanding (excluding 11,500,000 shares subject to redemption) | ||||
| Additional paid-in capital | ||||
| Accumulated deficit | ||||
| Total Stockholders' (Deficit) Equity | ||||
| Total Liabilities, Redeemable Common Stock and Stockholders' (Deficit) Equity |
Loading...
